Clear Street Markets LLC Abb Vie Inc. Put Options Transaction History

Clear Street Markets LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $662,550 - $824,500	5,000 Added 25.0%	25,000 $3.37 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $2.89 Million - $3.33 Million	20,000 New	20,000 $3.19 Million
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $402,630 - $461,790	3,000 Added 100.0%	6,000 $805,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $963,340 - $1.22 Million	-7,000 Reduced 70.0%	3,000 $459,000
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $9.24 Million - $11.5 Million	-70,000 Reduced 87.5%	10,000 $1.62 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $8.54 Million - $10.8 Million	79,500 Added 15900.0%	80,000 $10.8 Million
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $28,089 - $31,885	-264 Reduced 34.55%	500 $5.39 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $35,140 - $39,148	334 Added 77.67%	764 $8.61 Million
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $48,081 - $52,931	-470 Reduced 52.22%	430 $4.65 Million
Q4 2020 Feb 25, 2021	BUY	$80.49 - $108.67 $32,195 - $43,468	400 Added 80.0%	900 $96,000
Q3 2020 Oct 19, 2020	SELL	$85.91 - $100.83 $2,147 - $2,520	-25 Reduced 4.76%	500 $4.38 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $15,774 - $21,108	215 Added 69.35%	525 $5.15 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $128,355 - $194,602	-1,990 Reduced 86.52%	310 $2.36 Million
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $163,590 - $204,687	2,268 Added 7087.5%	2,300 $20.4 Million
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $2,491 - $3,072	32 New	32 $295,000

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $323B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.